Breaking News Instant updates and real-time market news.

MDCO

The Medicines Co.

$51.30

2.92 (6.04%)

16:42
03/20/17
03/20
16:42
03/20/17
16:42

Partner Fund reports 3.6% passive stake in The Medicines Co.

  • 20

    Mar

  • 21

    Mar

MDCO The Medicines Co.
$51.30

2.92 (6.04%)

01/06/17
JEFF
01/06/17
NO CHANGE
Target $49
JEFF
Buy
Amgen ruling could mean 'blue skies' for Medicines Co., says Jefferies
Jefferies analyst Biren Amin raised his price target for The Medicines Co. (MDCO) to $49 from $43 after the District Court of Delaware ruled in favor of Amgen (AMGN) on the permanent injunction against Sanofi (SNY) and Regeneron's (RENG) Praluent. The ruling should have a favorable read-through to Medicines' inclisiran since the drug is "completely unique to the monoclonal antibody approach" and therefore would not infringe on Amgen's patents, Amin tells investors in a research note titled "Injunction on Sanofi/REGN's Praluent Could Mean Blue Skies for Inclisiran." The analyst raised his inclisiran peak sales estimates to $2.4B in 2027 and keeps a Buy rating on Medicines shares. The stock is up $2.98, or 8%, to $38.50 in pre-market trading.
03/17/17
LEER
03/17/17
NO CHANGE
LEER
Outperform
Leerink reiterates Outperform on Medicines after Amgen data
Leerink analyst Joseph Schwartz says Amgen's (AMGN) cholesterol lowering data this morning is less positive than expectations, in part due to management's bullishness ahead of the news. The analyst sees a "less than perfect read-through" to The Medicines Co. (MDCO), however, since the company is likely to study inclisiran in patients with more elevated cholesterol going forward. He reiterates an Outperform rating on Medicines shares. The stock is morning trading is down 21% to $41.38.
03/17/17
JPMS
03/17/17
NO CHANGE
JPMS
The Medicines Co. selloff on Amgen data overdone, says JPMorgan
03/17/17
JPMS
03/17/17
NO CHANGE
JPMS
Overweight
Amgen data do not justify Medicines selloff, says JPMorgan
JPMorgan analyst Jessica Fye believes today's cholesterol data from Amgen (AMGN) do not justify the downward move in shares of The Medicines Co. (MDCO). The analyst sees a "clear clinical benefit" from Amgen's Repatha, which she thinks support the likelihood of clinical success and value for Medicines' inclisiran. The analyst remains comfortable with her 70% probability of success and $1.6B peak sales forecast for inclisiran. Fye keeps an Overweight rating on Medicines and believes the 18% selloff today is overdone.

TODAY'S FREE FLY STORIES

O

Realty Income

$57.92

0.49 (0.85%)

16:33
07/26/17
07/26
16:33
07/26/17
16:33
Hot Stocks
Realty Income sees FY17 EPS $1.15-$1.20, consensus $1.22 »

Company estimates FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

WHR

Whirlpool

$190.19

-0.76 (-0.40%)

16:33
07/26/17
07/26
16:33
07/26/17
16:33
Earnings
Whirlpool reports Q2 EPS $3.35, consensus $3.54 »

Reports Q2 revenue $5.3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMO

Capstead Mortgage

$9.99

-0.06 (-0.60%)

16:32
07/26/17
07/26
16:32
07/26/17
16:32
Earnings
Capstead Mortgage reports Q2 EPS 14c, consensus 20c »

Book value per common…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

BPI

Bridgepoint Education

$12.29

-0.98 (-7.39%)

16:32
07/26/17
07/26
16:32
07/26/17
16:32
Earnings
Bridgepoint Education reports Q2 EPS 21c, consensus 23c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 10

    Aug

BDGE

Bridge Bancorp

$32.90

-0.7 (-2.08%)

16:32
07/26/17
07/26
16:32
07/26/17
16:32
Earnings
Breaking Earnings news story on Bridge Bancorp »

Bridge Bancorp reports Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

QEP

QEP Resources

$9.27

0.07 (0.76%)

16:31
07/26/17
07/26
16:31
07/26/17
16:31
Earnings
QEP Resources reports Q2 adjusted EPS (12c), consensus (20c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 14

    Aug

MPWR

Monolithic Power

$106.79

1.86 (1.77%)

16:31
07/26/17
07/26
16:31
07/26/17
16:31
Earnings
Breaking Earnings news story on Monolithic Power »

Monolithic Power sees Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 08

    Aug

  • 10

    Aug

  • 15

    Aug

UDR

UDR, Inc.

$39.19

0.51 (1.32%)

16:31
07/26/17
07/26
16:31
07/26/17
16:31
Earnings
UDR, Inc. backs FY17 EPS view of 31c-36c, consensus 28c »

Reaffirmed FFO per share…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

FFIV

F5 Networks

$128.20

0.18 (0.14%)

16:30
07/26/17
07/26
16:30
07/26/17
16:30
Earnings
F5 Networks sees Q4 non-GAAP EPS $2.20-$2.23, consensus $2.24 »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 05

    Sep

MPWR

Monolithic Power

$106.79

1.86 (1.77%)

16:30
07/26/17
07/26
16:30
07/26/17
16:30
Earnings
Monolithic Power reports Q2 EPS 68c, consensus 67c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 08

    Aug

  • 10

    Aug

  • 15

    Aug

O

Realty Income

$57.92

0.49 (0.85%)

16:30
07/26/17
07/26
16:30
07/26/17
16:30
Earnings
Realty Income reports Q2 EPS 30c, consensus 32c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

FMNB

Farmers National Banc

$14.35

-0.4 (-2.71%)

16:30
07/26/17
07/26
16:30
07/26/17
16:30
Earnings
Farmers National Banc reports Q2 EPS 21c, consensus 22c »

Total loans were $1.51…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRCY

Mercury Systems

$43.86

-0.13 (-0.30%)

16:30
07/26/17
07/26
16:30
07/26/17
16:30
Hot Stocks
Mercury Systems receives $5.5M order »

Mercury Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 07

    Aug

ESND

Essendant

$13.41

-0.42 (-3.04%)

16:30
07/26/17
07/26
16:30
07/26/17
16:30
Earnings
Essendant sees FY17 sales decline of 6%-9%, consensus $5.22B »

Management said, "In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

16:30
07/26/17
07/26
16:30
07/26/17
16:30
Options
Preliminary option volume of 17.4M today »

Preliminary option volume…

NTRI

Nutrisystem

$62.95

1.3 (2.11%)

16:30
07/26/17
07/26
16:30
07/26/17
16:30
Hot Stocks
Breaking Hot Stocks news story on Nutrisystem »

Nutrisystem trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

UDR

UDR, Inc.

$39.19

0.51 (1.32%)

16:29
07/26/17
07/26
16:29
07/26/17
16:29
Earnings
UDR, Inc. reports Q2 AFFO 43c vs. 41c last year »

UDR reports Q2 Funds from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

FFIV

F5 Networks

$128.20

0.18 (0.14%)

16:29
07/26/17
07/26
16:29
07/26/17
16:29
Earnings
F5 Networks reports Q3 non-GAAP EPS $2.03, consensus $2.03 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 05

    Sep

FORR

Forrester

$41.60

0.15 (0.36%)

16:29
07/26/17
07/26
16:29
07/26/17
16:29
Earnings
Forrester sees FY17 pro forma EPS $1.13-$1.20, consensus $1.17 »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

BAC

Bank of America

$24.21

-0.27 (-1.10%)

, PYPL

PayPal

$58.79

0.53 (0.91%)

16:29
07/26/17
07/26
16:29
07/26/17
16:29
Hot Stocks
PayPal, BofA partner to enable in-store payments and account linking »

Bank of America (BAC) and…

BAC

Bank of America

$24.21

-0.27 (-1.10%)

PYPL

PayPal

$58.79

0.53 (0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 09

    Aug

  • 10

    Aug

AXTI

AXT, Inc.

$7.60

0.25 (3.40%)

16:28
07/26/17
07/26
16:28
07/26/17
16:28
Earnings
AXT, Inc. reports Q2 EPS 5c, consensus 5c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 03

    Aug

  • 10

    Aug

  • 19

    Sep

UDR

UDR, Inc.

$39.19

0.51 (1.32%)

16:28
07/26/17
07/26
16:28
07/26/17
16:28
Earnings
UDR, Inc. reports Q2 EPS 3c, consensus 6c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

ESND

Essendant

$13.41

-0.42 (-3.04%)

16:28
07/26/17
07/26
16:28
07/26/17
16:28
Earnings
Essendant reports Q2 adjusted EPS 28c, consensus 37c »

Reports Q2 revenue $1.3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

KS

KapStone

$22.52

-0.17 (-0.75%)

16:28
07/26/17
07/26
16:28
07/26/17
16:28
Earnings
KapStone reports Q2 adjusted EPS 27c, consensus 27c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

FORR

Forrester

$41.60

0.15 (0.36%)

16:28
07/26/17
07/26
16:28
07/26/17
16:28
Earnings
Forrester sees Q3 pro forma EPS 21c-25c, consensus 26c »

Sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.